Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Oral Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20 mg in Healthy Adult Human Subjects Under Fasting and Fed Conditions

NCT05416957 is registered in ClinicalTrials.gov with Seasons Biotechnology (Taizhou) Co., Ltd. as lead sponsor.

NCT NCT05416957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05416957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Oral Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20 mg in Healthy Adult Human Subjects Under Fasting and Fed Conditions
Lead sponsor
Seasons Biotechnology (Taizhou) Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
September 18, 2022
Completion date
October 27, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)